Alexandria Real Estate Equities
ARE
#2417
Rank
$7.55 B
Marketcap
$43.38
Share price
-1.04%
Change (1 day)
-14.66%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) Fails to deliver data

Key failure to deliver metrics for Alexandria Real Estate Equities :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013

Volume in USD (price x number of shares), data since 2013

Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$22.24 M-45.99%
2023$41.18 M-64.08%
2022$0.11 B22.18%
2021$93.85 M-16.64%
2020$0.11 B38.94%
2019$81.03 M-10.89%
2018$90.94 M-43.57%
2017$0.16 B192.01%
2016$55.19 M125.93%
2015$24.42 M11.4%
2014$21.92 M875.57%
2013$2.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
$34.29 M$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$42.08 M$0.36 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$29.91 M$0.45 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$17.8 M$79.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$33.85 M$97.88 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$19.01 M$94.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$6.04 M$37.69 M๐Ÿ‡บ๐Ÿ‡ธ USA